Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids

被引:423
作者
McLaren, J
Prentice, A
CharnockJones, DS
Millican, SA
Muller, KH
Sharkey, AM
Smith, SK
机构
[1] UNIV CAMBRIDGE,ROSIE MATERN HOSP,DEPT OBSTET & GYNAECOL,REPROD MOL RES GRP,CAMBRIDGE CB2 2NS,ENGLAND
[2] UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE CB2 1QJ,ENGLAND
基金
英国惠康基金;
关键词
endometriosis; VEGF; angiogenesis; VEGF receptors (flt; KDR);
D O I
10.1172/JCI118815
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Angiogenesis is important in the pathophysiology of endometriosis, a condition characterized by implantation of ectopic endometrium in the peritoneal cavity. Vascular endothelial growth factor (VEGF) is a potent angiogenic factor involved in physiological and pathological angiogenesis, and elevated levels of VEGF are found in peritoneal fluid of patients with endometriosis. Our aim was to investigate the site of expression and regulation of VEGF in endometriosis. VEGF immunoreactivity was found in tissue macrophages present in ectopic endometrium and in activated peritoneal fluid macrophages. Macrophage activation was highest in women with endometriosis, and media conditioned by peritoneal fluid macrophages from these women caused a VEGF-dependent increase in endothelial cell proliferation above that seen from normal women. Peritoneal fluid macrophages secreted VEGF in response to ovarian steroids, and this secretion was enhanced after activation with lipopolysaccharide. Peritoneal fluid macrophages expressed receptors for steroid hormones. VEGF receptors fit and KDR (kinase domain receptor) were also detected, suggesting autocrine regulation. During the menstrual cycle, expression of fit was constant but that of KDR was increased in the luteal phase, at which time the cells migrated in response to VEGF. KDR expression and the migratory response were significantly higher in patients with endometriosis. This study demonstrates that activated macrophages are a major source of VEGF in endometriosis and that this expression is regulated directly by ovarian steroids.
引用
收藏
页码:482 / 489
页数:8
相关论文
共 52 条
[1]   VASCULAR ENDOTHELIAL GROWTH-FACTOR ACTS AS A SURVIVAL FACTOR FOR NEWLY FORMED RETINAL-VESSELS AND HAS IMPLICATIONS FOR RETINOPATHY OF PREMATURITY [J].
ALON, T ;
HEMO, I ;
ITIN, A ;
PEER, J ;
STONE, J ;
KESHET, E .
NATURE MEDICINE, 1995, 1 (10) :1024-1028
[2]  
BERGQVIST A, 1992, MODERN APPROACHES EN, P257
[3]   VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) GENE IS EXPRESSED DIFFERENTIALLY IN NORMAL-TISSUES, MACROPHAGES, AND TUMORS [J].
BERSE, B ;
BROWN, LF ;
VANDEWATER, L ;
DVORAK, HF ;
SENGER, DR .
MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (02) :211-220
[4]   EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND ITS RECEPTORS FLT AND KDR IN OVARIAN-CARCINOMA [J].
BOOCOCK, CA ;
CHARNOCKJONES, DS ;
SHARKEY, AM ;
MCLAREN, J ;
BARKER, PJ ;
WRIGHT, KA ;
TWENTYMAN, PR ;
SMITH, SK .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (07) :506-516
[5]  
BREIER G, 1992, DEVELOPMENT, V114, P521
[6]   STEROID SEX-HORMONES REGULATE THE RELEASE OF TUMOR-NECROSIS-FACTOR BY MACROPHAGES [J].
CHAO, TC ;
VANALTEN, PJ ;
GREAGER, JA ;
WALTER, RJ .
CELLULAR IMMUNOLOGY, 1995, 160 (01) :43-49
[7]   VASCULAR ENDOTHELIAL GROWTH-FACTOR RECEPTOR LOCALIZATION AND ACTIVATION IN HUMAN TROPHOBLAST AND CHORIOCARCINOMA CELLS [J].
CHARNOCKJONES, DS ;
SHARKEY, AM ;
BOOCOCK, CA ;
AHMED, A ;
PLEVIN, R ;
FERRARA, N ;
SMITH, SK .
BIOLOGY OF REPRODUCTION, 1994, 51 (03) :524-530
[8]   IDENTIFICATION AND LOCALIZATION OF ALTERNATELY SPLICED MESSENGER-RNAS FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR IN HUMAN UTERUS AND ESTROGEN REGULATION IN ENDOMETRIAL CARCINOMA CELL-LINES [J].
CHARNOCKJONES, DS ;
SHARKEY, AM ;
RAJPUTWILLIAMS, J ;
BURCH, D ;
SCHOFIELD, JP ;
FOUNTAIN, SA ;
BOOCOCK, CA ;
SMITH, SK .
BIOLOGY OF REPRODUCTION, 1993, 48 (05) :1120-1128
[9]  
CONNOLLY DT, 1994, J CLIN INVEST, V84, P213
[10]  
DELEON FD, 1986, OBSTET GYNECOL, V68, P189